REGINA: A Phase II Trial of Neoadjuvant Regorafenib (rego) in Combination with Nivolumab (nivo) and Short-Course Radiotherapy (SCRT) in Intermediate-Risk, Stage II-III Rectal Cancer (RC).
Annals of Oncology(2021)
关键词
Neoadjuvant Therapy
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要